Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0V6OZ
|
|||
| Drug Name |
CN-105
|
|||
| Synonyms |
5-Nitroisoquinoline; 607-32-9; Isoquinoline, 5-nitro-; 5-Nitro-isoquinoline; MLS002637661; PYGMPFQCCWBTJQ-UHFFFAOYSA-N; 5-nitroisochinolin; EINECS 210-133-8; 5-nitro isoquinoline; PubChem6272; AI3-61887; Maybridge1_001820; ACMC-1AV1Q; AC1Q1X2S; 5-Nitroisoquinoline, 98%; Oprea1_032003; SCHEMBL1010663; AC1Q201M; AC1L2B31; CHEMBL353253; PYGMPFQCCWBTJQ-UHFFFAOYSA-; KS-00000DJC; CTK2F2846; ZINC93213; HMS546K16; DTXSID00209511; NSC3017; MolPort-001-761-771; HMS3078A13; ACT09900; ALBB-021274; NSC-3017; ANW-33564; SBB066313; MFCD00006905
Click to Show/Hide
|
|||
| Indication | Nontraumatic intracerebral hemorrhage [ICD-11: 8B00.4; ICD-10: I61.5] | Phase 2 | [1], [2], [3] | |
| Company |
AegisCN Raleigh, NC
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C9H6N2O2
|
|||
| Canonical SMILES |
C1=CC2=C(C=CN=C2)C(=C1)[N+](=O)[O-]
|
|||
| InChI |
1S/C9H6N2O2/c12-11(13)9-3-1-2-7-6-10-5-4-8(7)9/h1-6H
|
|||
| InChIKey |
PYGMPFQCCWBTJQ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 607-32-9
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Apolipoprotein E (APOE) | Target Info | Agonist | [1], [2], [3] |
| KEGG Pathway | Alzheimer's disease | |||
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | |||
| FSH Signaling Pathway | ||||
| Wnt Signaling Pathway | ||||
| Reactome | Chylomicron-mediated lipid transport | |||
| HDL-mediated lipid transport | ||||
| Scavenging by Class A Receptors | ||||
| Retinoid metabolism and transport | ||||
| WikiPathways | Statin Pathway | |||
| Apoptosis-related network due to altered Notch3 in ovarian cancer | ||||
| Binding and Uptake of Ligands by Scavenger Receptors | ||||
| Visual phototransduction | ||||
| Lipid digestion, mobilization, and transport | ||||
| Alzheimers Disease | ||||
| Vitamin B12 Metabolism | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.